HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Tacedinaline

HCID 2746
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
112522-64-2
Standard SMILES
CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1
InChIKey
VAZAPHZUAVEOMC-UHFFFAOYSA-N
Molecular formula
C15H15N3O2
Average molar mass
269.3 g/mol
Monoisotopic mass
269.11642673

Overview

Tacedinaline is a benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Also used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers. It has a role as an antineoplastic agent and an EC 3.5.1.98 (histone deacetylase) inhibitor. It is a member of acetamides, a member of benzamides and a substituted aniline. It is functionally related to a 1,2-phenylenediamine.

Names & identifiers

Preferred name
Tacedinaline
IUPAC
4-acetamido-N-(2-aminophenyl)benzamide
English name
Tacedinaline
Molecular formula
C15H15N3O2
Molecular weight
269.3

Names & synonyms

Tacedinaline112522-64-2ci-9944-acetamido-N-(2-aminophenyl)benzamideCI 994Tacedinalina4-(Acetylamino)-N-(2-aminophenyl)benzamideN-acetyldinalineGoe 5549Goe-5549PD-123654PD 123654
Show more names
acetyldinalineCS-617Cl-994CI994, >=99%
C.I. 994UMF554N5FGN-(2-aminophenyl)-4-acetamidobenzamideCHEBI:90195DTXSID60150095tacedinalinumN-acetyl DinalineRefChem:890200

Database identifiers

CAS
112522-64-2、58338-59-3
PubChem CID
2746
DTXSID
DTXSID60150095
ChEMBL
CHEMBL235191
ChEBI
CHEBI:90195
UNII
UMF554N5FG
EC Number
631-226-3
Nikkaji
J545.180I

Properties

Computed structural propertiesFilling in

XLogP
1.3
Topological polar surface area
84.2 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
3
Rotatable bonds
3
Heavy atoms
20
Formal charge
0
Complexity
351

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP0.82

Physicochemical properties

Melting point
216.1 °C · 216.1 °C
Boiling point
450.6 · 450.6±30.0 °C(Predicted)
Density
1.322 · 1.322±0.06 g/cm3(Predicted)
RTECS
8702023 · CU8702023
storage temp.
2 · Keep in dark place,Inert atmosphere,2-8°C
solubility
Soluble in DMSO
pka
13.15 · 13.15±0.70(Predicted)
form
powder
color
off-white
Sensitive
Air Sensitive
Stability
1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]

P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)

Aggregated GHS information provided per 67 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Hazard Classes and CategoriesEye Irrit. 2 (100%)

Safety data

PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
hs_code
2924.29.7790
risk_code
36
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xi
safety_code
26
Storage Class
11 - Combustible Solids
Hazard statements
H319
Hazard Classifications
Eye Irrit. 2
Precautionary statements
P305+P351+P338

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Substances that inhibit or prevent the proliferation of NEOPLASMS.

Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains.

Applications · 2 items

DescriptionCI-994 (112522-64-2) is an orally active histone deacetylase (HDAC) inhibitor, IC50 = 0.9, 0.9, 1.2 and >20 μM for HDAC1, HDAC2, HDAC3 and HDAC8 respectively.1 Mediates G1 cell cycle arrest, inhibits proliferation and induces apoptosis in vitro and in vivo.2,3 Increases neuroplasticity during memory extinction.4 Protects beta cells from cytokine-induced apoptosis.4

UsesTacedinaline is a histone deacetylase (HDAC) inhibitor. Tacedinaline is an anti-cancer agent as HDAC inhibitors block angiogenesis, arrest cell growth, and lead to differentiation and apoptosis in tumor cells. Studies show Tacedinaline to be effective against acute myeloid leukemia in vitro and in vivo when used in combination with conventional anti-cancer agents.

Upstream & downstream products

Upstream raw materials

tert-butyl 2-nitrophenylcarbamate(2-Amino-phenyl)-carbamic acid tert-butyl ester4-acetamidobenzoic acid2-Nitroanilineo-PhenylenediamineCarbamic acid, N-[2-[[4-(acetylamino)benzoyl]amino]phenyl]-, 1,1-dimethylethyl ester

Related reactions

8 records
New reaction record
HRID 846811 reaction equation
HRID 846811As product
HRID 1026180 reaction equation
HRID 1026180As product
HRID 1026183 reaction equation
HRID 1026183As product
HRID 1129044 reaction equation
HRID 1129044As product
HRID 1776956 reaction equation
HRID 1776956As product
HRID 1776959 reaction equation
HRID 1776959As product
HRID 2363242 reaction equation
HRID 2363242As product
HRID 2363245 reaction equation
HRID 2363245As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
InChI
1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)
InChIKey
VAZAPHZUAVEOMC-UHFFFAOYSA-N
SMILES
CC(=O)Nc1ccc(cc1)C(=O)Nc2ccccc2N
EWG's Food Scores
1 · 1
NCI Dictionary of Cancer Terms
-994 · CI-994; N-acetyldinaline
FDA UNII
554 N5FG · UMF554N5FG
NCI Drug Dictionary
tacedinaline
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
319 · H319
Precautionary statements
305 · P305+P351+P338
PPE
95 · dust mask type N95 (US), Eyeshields, Gloves
Hazard Codes
Xi
Risk Statements
36 · 36
Safety Statements
26 · 26
WGK Germany
3 · 3
HS Code
2924.29 · 2924.29.7790
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
2 · Eye Irrit. 2
Benzamide, 4-(acetylamino)-N-(2-aminophenyl)-, 2,2,2-trifluoroacetate (1:1)
Sodium bicarbonate
Dichloromethane
Trifluoroacetic acid
Additional notes · 1 item

DefinitionChEBI: A benzamide obtained by formal condensation of the carboxy group of 4-acetamidobenzoic acid with one of the amino groups of 1,2-phenylenediamine. An oral cytostatic drug with impressive differential activity against leukemic cells and normal stem-cells. Al o used in combination therapy for selected tumors including non-smoll cell lung, pancreatic, breast, and colorectal cancers.